Role of Monocyte Chemoattractant Protein-1 and its Receptor,CCR-2, in the Pathogenesis of Bleomycin-Induced Scleroderma
- 1 September 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (3) , 510-516
- https://doi.org/10.1046/j.1523-1747.2003.12408.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Chemokines: new ligands, receptors and activitiesPublished by Elsevier ,2001
- Chemokine expression by systemic sclerosis fibroblasts: Abnormal regulation of monocyte chemoattractant protein 1 expressionArthritis & Rheumatism, 2001
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- Effect of Superoxide Dismutase on Bleomycin-Induced Dermal Sclerosis: Implications for the Treatment of Systemic SclerosisJournal of Investigative Dermatology, 1999
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Connective tissue metabolism including cytokines in sclerodermaCurrent Opinion in Rheumatology, 1995
- Mast Cells: Accessory Cells Which Potentiate FibrosisInternational Reviews of Immunology, 1995
- Interleukin‐4 stimulates collagen gene expression in human fibroblast monolayer cultures Potential role in fibrosisFEBS Letters, 1992
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990
- Systemic scleroderma: Clinical and pathophysiologic aspectsJournal of the American Academy of Dermatology, 1988